Construction of a Deep Learning-Based Precise Diagnostic Framework for Bladder Tumors Using Ultrasound: A Multicenter, Ambispective Cohort Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorPeking University First Hospital

About this trial

This study aims to develop an ultrasound image-based deep learning system to enable automatic segmentation, T-staging, and pathological grading prediction of bladder tumors. It seeks to enhance the objectivity, accuracy, and efficiency of bladder cancer diagnosis, reduce reliance on physician experience, and provide support for precision medicine and resource optimization.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

Age >85 years;

Patients unable to undergo abdominal/transrectal ultrasound (e.g., uncooperative individuals, technically inadequate images);

History of bladder tumor surgery, radiotherapy, chemotherapy, or systemic therapy within 3 months; ④ Patients with indwelling medical devices (e.g., double-J ureteral stents, urinary catheters);

Failure to undergo bladder tumor surgery within 2 weeks post-ultrasound; ⑥ Non-urothelial carcinoma or pathologically unconfirmed diagnoses.

Trial population

This study consecutively enrolled patients with suspected bladder tumors prospectively registered at the Department of Urology, Peking University First Hospital and Shanxi Province Cancer Hospital between May 2025 and May 2027.

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

  • observational diagnostic model development

    Other intervention

    observational diagnostic model development

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Overall Diagnostic Accuracy

Time frame
From may 2025 to may 2027

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.